BTG - SYNGAP1 Scientific Conferences

BTG - Awareness, Advocacy, Education & Research


BTG'S - 3rd International SYNGAP1 Scientifc Conference

*Virtual - Live Stream Interactive Format

Click Here to Register for the Conference
Click Here to Register for The Young Investigator Workshop


*A detailed agenda, listing all times and speakers, will be available by 9/30/2020

Tuesday, November 17, 2020


SESSION 1: Career Development    

Keynote Speaker:
 Jimmy Holder, MD, PhD, Texas Children's Hospital, Baylor College of Medicine

   Breakout Session A:  Clinical/Translational Panel
   Constance Smith-Hicks, MD, PhD, Kennedy Krieger Institute, Johns Hopkins School of Medicine
   Jimmy Holder, MD, PhD, Texas Children's Hospital, Baylor College of Medicine
   Bradley Schlaggar, MD, PhD, President/CEO, Kennedy Krieger Institute

  Breakout Session B:  Basic Science Panel
Julia Dallman, PhD, University of Miami
  Richard Huganir, PhD, Johns Hopkins School of Medicine
  Gavin Rumbaugh, PhD, Scripps Research Institute

Morning Break

SESSION 2: Panel Presentation - NIH Grant Mechanisms & Programs for Young Investigators Funding Mechanisms Divisions of Neuroscience, Clinical Research and Translational Research at NINDS  
   Lead Panel Speaker:
 Vicky Whittemore, PhD, Program Director, NIH/National Institute of Neurological Disorders and Stroke (NINDS), Division of   Neuroscience, Channels, Synapses and Circuits

*Live Virtual - Lunch for SYNGAP1 Families, Young Investigators and Experts

SESSION 3: Abstract/Poster Presentations (2:00 pm - 5:00 pm, EST)

Closing Remarks - Constance Smith-Hicks, MD, PhD, Kennedy Krieger Institute

*Live Virtual - Happy Hour for Young Investigators and Experts

Calling all Young Neuroscience and SYNGAP Investigators!

The 1st day of the 2020 Virtual International SYNGAP1 Scientific Conference, is designed specifically to meet the interests and needs of Young/New Neuroscience Investigators! We have an amazing lineup of accomplished neuroscience/SynGAP research scientists and clinical/research experts scheduled to present on November 17, 2020, for our Young Investigators' Career Development Workshop.

In addition, we invite and encourage Young/New Investigators, interested in Neuroscience and/or SYNGAP Research, to submit an abstract/poster submission!  All Young Investigator Poster/Abstract submissions will be reviewed and scored by the Conference's Scientific Research Committee. Young Investigators, who submit a poster/abstract, will have an opportunity to pre-record and present their work. The top four poster/abstracts, based upon merit, are eligible to be present during a special session, to be held on the morning of November 19th.

Don't miss this exciting opportunity!

Deadline to submit an abstract/poster is: September 1, 2020 *Deadline to submit is now closed
Contact Us if you have any questions.
*Please Note:  Registration for the Workshop and Conference are separate.
Links to Registration Sites are located at the top of this page.
Wednesday, November 18, 2020


Introduction and Charge for the Symposium

Opening Remarks by Conference Co-Chairs:
  Gavin Rumbaugh, PhD, Scripps Research Institute
  Jimmy Holder, MD, PhD, Texas Children’s Hospital, Baylor College of Medicine
  Constance Smith-Hicks, MD, PhD, Kennedy Krieger Institute, Johns Hopkins School of Medicine
  Monica Weldon, President/CEO, Bridge the Gap –SYNGAP Education and Research Foundation 

Keynote Address:  Ann Pariser, MD, Director, Office of Rare Diseases Research, NIH/National Center for Advancing Translational Sciences (NCATS)

SESSION 1: SYNGAP1 Clinical Disorder, Chaired by Constance Smith-Hicks, MD, PhD Speaker    
  Speaker Presentations
  Session 1 Panel Discussion –
All Session 1 Speakers  

* LUNCH BREAK - Young Investigator Poster Sessions Available for Viewing  

SESSION 2:  SynGAP Neurobiology
  Chaired by: 
Gavin Rumbaugh, PhD, Scripps Research Institute &
                          Richard Huganir, PhD, Johns Hopkins School of Medicine
  Speaker Presentations
  Session 2 Panel Discussion –
All Session 2 Speakers

SESSION 3:  Translating SYNGAP1: From Bench to Bedside
  Chaired by:
Jimmy Holder, MD, PhD, Texas Children’s Hospital, Baylor College of Medicine 
  Speaker Presentations
  Panel Discussion –
All Session 3 Speakers
Thursday, November 19, 2020

Day 3: Main Symposium    8:00 am –11:30 am  

SESSION 4: Young Investigator Poster/Abstract Presentations
  Chaired by:
Rick Huganir, PhD, Johns Hopkins School of Medicine
  Speaker Presentations:  *Selected from submitted and reviewed Y.I. Poster/Abstracts
    Young Investigator Presentation 1: *tbd        
    Young Investigator Presentation 2:  *tbd     
    Young Investigator Presentation 3:  *
    Young Investigator Presentation 4:  *

SESSION 5:  Accelerating Treatments for Children with Rare Genetic Disorders
Chaired by:
Constance Smith-Hicks, MD, PhD, Kennedy Krieger Institute, Johns Hopkins School of Medicine and
                        Jimmy Holder, MD, PhD, Texas Children's Hospital, Baylor College of Medicine
Speaker Presentations        
Panel Discussion – All Session 5 Speakers, plus, Basic, Clinical, and Translational Science Expert Discussion Leaders, will present a summary of symposium discussions and presentations.   


*Bridge the Gap's Virtual, SYNGAP1 Externally Led-Patient Focused Drug Development (EL-PFDD) Meeting will begin at 12:30 pm (Eastern,) after the conclusion of the SYNGAP1 International Conference. All interested individuals who wish to view and/or participate in the Virtual SYNGAP1 EL-PFDD, must register online. Meeting Registration is free and all are welcome!!!  
Click Here for SYNGAP1 EL-PFDD Meeting Information
Bridge the Gap’s International SYNGAP1 Conference provides a cutting-edge, scientific and educational
forum focused on bringing together a diverse group of SYNAP1 Community stakeholders.  SYNGAP1 Community stakeholders include - research scientists, clinical specialists, SYNGAP1 Families, industry, academic, governmentand community leaders.  

In addition, the conferences provide opportunities to bring  together scientists and clinicians actively involved in SYNGAP1 Research with trainees,young investigators, and underrepresented minorities, as well as, experts in the development of targeted therapies related to neurodevelopmental disorders.  Our goal is to increase participation of trainees,young investigators and underrepresented minorities in neurodevelopmental disorder research and to encourage the development of targeted therapies to treat SYNGAP1 and related neurodevelopmental disorders.

The conferences are designed to maximize scientific resources, encourage opportunities for collaboration and provide a forum that is inclusive for SYNGAP1 families and caregivers.  Each conference features a broad range of sessiontopics related to SYNGAP1 mutations, related neurodevelopmental disorders, published and unpublished research data and patient-centric study design. Time is allotted during each presentation for SYNGAP1 experts to lead discussions on current and future avenues of research.
Need more information or have questions about the conference?
Contact Us